Suppr超能文献

采用三维图像分析比较低结晶碳酸磷灰石和 Bio-Oss 在鼻窦提升中的性能。

Comparison of the performances of low-crystalline carbonate apatite and Bio-Oss in sinus augmentation using three-dimensional image analysis.

机构信息

Department of Oral and Maxillofacial Implantology, Kanagawa Dental University, 82 Inaoka-cho, Yokosuka, 238-8580, Japan.

出版信息

Int J Implant Dent. 2021 Mar 23;7(1):24. doi: 10.1186/s40729-021-00303-4.

Abstract

BACKGROUND

In locations where the alveolar bone height is low, such as at the maxillary molars, implant placement can be difficult, or even impossible, without procedures aimed at generating new bone, such as sinus lifts. Various types of bone graft materials are used after a sinus lift. In our study, a three-dimensional image analysis using a volume analyzer was performed to measure and compare the volume of demineralized bovine bone mineral (Bio-Oss®) and carbonate apatite (Cytrans®) after a sinus lift, as well as the amount of bone graft material resorption. Patient data were collected from cone-beam computed tomography images taken before, immediately following, and 6 months after the sinus lift. Using these images, both the volume and amount of resorption of each bone graft material were measured using a three-dimensional image analysis system.

RESULTS

The amount of bone resorption in the Bio-Oss®-treated group was 25.2%, whereas that of the Cytrans®-treated group was 14.2%. A significant difference was found between the two groups (P < 0.001).

CONCLUSIONS

Our findings indicate that the volume of bone resorption was smaller in the Cytrans®-treated group than in the Bio-Oss®-treated group, suggesting that Cytrans® is more promising for successful implant treatments requiring a sinus lift.

摘要

背景

在牙槽骨高度较低的部位,如在上颌磨牙区,若不进行旨在生成新骨的手术,如窦提升术,种植体的植入可能会很困难,甚至不可能。在窦提升术后,会使用各种类型的骨移植材料。在我们的研究中,使用体积分析器进行了三维图像分析,以测量和比较窦提升术后脱矿牛骨矿物质(Bio-Oss®)和碳酸磷灰石(Cytrans®)的体积以及骨移植材料吸收量。从接受窦提升术前、即刻和术后 6 个月的锥形束 CT 图像中收集患者数据。使用这些图像,使用三维图像分析系统测量了每种骨移植材料的体积和吸收量。

结果

Bio-Oss®治疗组的骨吸收量为 25.2%,而 Cytrans®治疗组的骨吸收量为 14.2%。两组之间存在显著差异(P < 0.001)。

结论

我们的研究结果表明,Cytrans®治疗组的骨吸收量小于 Bio-Oss®治疗组,这表明 Cytrans®在需要窦提升的成功种植体治疗中更有前途。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/419d/7985233/47dd4dcc2946/40729_2021_303_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验